BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19423368)

  • 1. A prospective study of the presentation and management of dancing eye syndrome/opsoclonus-myoclonus syndrome in the United Kingdom.
    Pang KK; de Sousa C; Lang B; Pike MG
    Eur J Paediatr Neurol; 2010 Mar; 14(2):156-61. PubMed ID: 19423368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome.
    Brunklaus A; Pohl K; Zuberi SM; de Sousa C
    Arch Dis Child; 2012 May; 97(5):461-3. PubMed ID: 21460401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dancing Eye Syndrome associated with spontaneous recovery and normal neurodevelopment.
    Ki Pang K; Lynch BJ; Osborne JP; Pike MG
    Eur J Paediatr Neurol; 2010 Mar; 14(2):178-81. PubMed ID: 19541513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dancing eyes, dancing feet: opsoclonus-myoclonus in an 18-month-old child with neuroblastoma.
    Badaki OB; Schapiro ES
    Pediatr Emerg Care; 2007 Dec; 23(12):885-8. PubMed ID: 18091597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies in childhood opsoclonus-myoclonus syndrome.
    Blaes F; Pike MG; Lang B
    J Neuroimmunol; 2008 Sep; 201-202():221-6. PubMed ID: 18687475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Opsoclonus myoclonus ataxia syndrome in Israel].
    Blumkin L; Lerman-Sagie T
    Harefuah; 2010 Jan; 149(1):24-8, 63. PubMed ID: 20422836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
    Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
    Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Opsoclonus-myoclonus syndrome in a 2 year old boy with prenatally diagnosed retroperitoneal tumour].
    Jamroz E; Głuszkiewicz E; Madziara W; Kiełtyka A
    Med Wieku Rozwoj; 2011; 15(2):151-6. PubMed ID: 22002047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS).
    Krasenbrink I; Fühlhuber V; Juhasz-Boess I; Stolz E; Hahn A; Kaps M; Hero B; Blaes F
    Neuropediatrics; 2007 Jun; 38(3):114-6. PubMed ID: 17985258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical profile and outcome of children with opsoclonus-myoclonus syndrome.
    Singhi P; Sahu JK; Sarkar J; Bansal D
    J Child Neurol; 2014 Jan; 29(1):58-61. PubMed ID: 23318697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Opsoclonus-myoclonus syndrome].
    Arroyo HA; Tringler N
    Medicina (B Aires); 2009; 69(1 Pt 1):64-70. PubMed ID: 19240003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulses.
    Ertle F; Behnisch W; Al Mulla NA; Bessisso M; Rating D; Mechtersheimer G; Hero B; Kulozik AE
    Pediatr Blood Cancer; 2008 Mar; 50(3):683-7. PubMed ID: 17226843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.
    Burke MJ; Cohn SL
    Pediatr Blood Cancer; 2008 Mar; 50(3):679-80. PubMed ID: 16900484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nationwide survey of opsoclonus-myoclonus syndrome in Japanese children.
    Hasegawa S; Matsushige T; Kajimoto M; Inoue H; Momonaka H; Oka M; Ohga S; Ichiyama T;
    Brain Dev; 2015 Aug; 37(7):656-60. PubMed ID: 25454391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae.
    Mitchell WG; Davalos-Gonzalez Y; Brumm VL; Aller SK; Burger E; Turkel SB; Borchert MS; Hollar S; Padilla S
    Pediatrics; 2002 Jan; 109(1):86-98. PubMed ID: 11773546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose pulsatile dexamethasone therapy in children with opsoclonus-myoclonus syndrome.
    Rostásy K; Wilken B; Baumann M; Müller-Deile K; Bieber I; Gärtner J; Möller P; Angelini P; Hero B
    Neuropediatrics; 2006 Oct; 37(5):291-5. PubMed ID: 17236108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroblastoma found in a 4-year-old after rituximab therapy for opsoclonus-myoclonus.
    Chang BH; Koch T; Hopkins K; Malempati S
    Pediatr Neurol; 2006 Sep; 35(3):213-5. PubMed ID: 16939863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome.
    Tate ED; Allison TJ; Pranzatelli MR; Verhulst SJ
    J Pediatr Oncol Nurs; 2005; 22(1):8-19. PubMed ID: 15574722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The opsoclonus–myoclonus syndrome.
    Sahu JK; Prasad K
    Pract Neurol; 2011 Jun; 11(3):160-6. PubMed ID: 21551110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed, recurrent opsoclonus-myoclonus syndrome responding to plasmapheresis.
    Armstrong MB; Robertson PL; Castle VP
    Pediatr Neurol; 2005 Nov; 33(5):365-7. PubMed ID: 16243225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.